Review found differences in estimated treatments for chlamydia and gonorrhea despite CDC guidelines

Published Date: 02 Mar 2023

A review of chlamydia and gonorrhea prevention studies conducted by the Regenstrief Institute found that rates of presumptive treatment (antibiotics before diagnosis) varied.

Read Full News

Latest News

Trump Administration Unfreezes $600 Million for Gavi for Global Vaccine Effort

The Trump administration said on Wednesday it will immediately release $600 million in congressionally appropriated funds for vaccines for ⁠the world's poorest countries...

Cyclosporiasis Cases in Michigan Surpass 10,000 in Ongoing Outbreak

Michigan health officials reported 10,077 cases of cyclosporiasis on Wednesday, an increase of 397 ⁠cases since their last update a day earlier.

IGRA vs TST: Which Test Better Detects Latent Tuberculosis?

Tuberculin skin test positivity exceeds interferon-gamma release assay positivity among healthcare workers and first responders, a meta-analysis finds.

UK Reports Rise in Cyclospora Infections Linked to Mexico Travel

The UK Health Security Agency (UKHSA) said on Thursday it was seeing a sharp rise in cyclospora infections among travellers ⁠returning from Mexico and urged people to follow...

US Lawmakers Press Health Secretary Robert F. Kennedy Jr. on Vaccine Settlement

(Corrects spelling of attorney's name in paragraphs 12, 13)

Michigan Reports 9,253 Cyclosporiasis Cases as Infection Outbreak Expands

Michigan health officials reported 9,253 cases of cyclosporiasis on Monday, an increase of 1,077 cases since their last update on Friday, as ⁠the intestinal infection...

Todays Updates

Defibrotide Prophylaxis May Reduce SOS Risk After HSCT

A study evaluates whether defibrotide prophylaxis during HSCT reduces the risk for sinusoidal obstruction syndrome in children with relapsed or refractory B-ALL receiving prior inotuzumab.

Todays Updates

Defibrotide Prophylaxis May Reduce SOS Risk After HSCT

A study evaluates whether defibrotide prophylaxis during HSCT reduces the risk for sinusoidal obstruction syndrome in children with relapsed or refractory B-ALL receiving prior inotuzumab.

Latest News

The Trump administration said on Wednesday it will immediately release $600 million in congressionally appropriated funds for vaccines for ⁠the world's poorest countries...

Michigan health officials reported 10,077 cases of cyclosporiasis on Wednesday, an increase of 397 ⁠cases since their last update a day earlier.

Tuberculin skin test positivity exceeds interferon-gamma release assay positivity among healthcare workers and first responders, a meta-analysis finds.

The UK Health Security Agency (UKHSA) said on Thursday it was seeing a sharp rise in cyclospora infections among travellers ⁠returning from Mexico and urged people to follow...

(Corrects spelling of attorney's name in paragraphs 12, 13)

Michigan health officials reported 9,253 cases of cyclosporiasis on Monday, an increase of 1,077 cases since their last update on Friday, as ⁠the intestinal infection...

News All Time

Carl H. June on CAR-T’s Next Frontier: Autoimmune Disease

In an interview, Carl H. June discusses how CAR-T therapy transformed blood cancer treatment, the challenges of extending it to solid tumors, and why autoimmune disease may be its next major frontier.

US Cyclosporiasis Cases Top 4,100 as CDC Investigates Lettuce-linked Outbreak

The Centers for Disease Control and Prevention has pegged the number of domestically acquired, lab-confirmed U.S. cyclosporiasis cases ⁠since May 1 at 4,173 after federal...

Congo Says Nearly 1,000 Die Of Ebola, Confirmed Cases Rise to 2,473

The ⁠number of confirmed Ebola ⁠cases in the ⁠Democratic Republic ‌of Congo has increased to 2,473, including ‌999 deaths, government data showed ‌on...

Kids Born in Lockdown Show Lower Executive Function at Age 4

Kids born in the first COVID lockdown in England show age-appropriate language and motor skills, but executive function remains the key area of concern at age 4 and may need extra support at school.

Cyclosporiasis Cases in Michigan Climb to Over 7,000, State Health Officials Say

Michigan health officials reported 7,171 cases linked to an outbreak of cyclosporiasis on Wednesday, up 600 cases since its ⁠last update on Tuesday.

Gilead, Merck Weekly HIV Pill Keeps Virus Suppressed in Late-stage Trials

Gilead Sciences and Merck said on Tuesday their experimental once-weekly HIV pill kept the virus suppressed in ⁠two late-stage trials, supporting regulatory filings for what...

Fewer Children Got US-backed HIV Treatment After Aid Cuts, Study Finds

(Refiles to add missing byline)

Cyclosporiasis Surge: A Clinician's Quick Guide

With a 34-state Cyclospora outbreak driving GI visits, Dr Levy breaks down diagnosis, testing pitfalls, and treatment clinicians need to know.

US FDA Says False-positive Lettuce Test Doesn't Change Taylor Farms Cyclospora Probe

The U.S. Food and Drug Administration on Monday defended publicizing a lettuce sample later found to be ⁠a false positive for cyclospora, saying the reversal does not...

What Has Made the Cyclospora Behind the US Outbreak So Challenging to Trace?

Cyclospora, the parasite behind thousands of suspected U.S. cases of a foodborne illness, has a long incubation period, and samples cannot be cultured in labs, making it...

Japanese Drugmaker Takeda's Qdenga Becomes First Dengue Vaccine Approved in India

Takeda Pharmaceutical's dengue vaccine Qdenga has been approved by India's drug regulator, making it the first such vaccine to be cleared in the country, the Japanese...

India's Serum Institute Partners With Gates MRI to Make Experimental TB Vaccine

(Corrects to fix typo in the headline)

New Zealand Confirms First H5N1 Bird Flu Case in Native Bird

New Zealand detected on Friday the first infection of a native bird ⁠by the deadly H5N1 bird flu, days after confirming a migratory seabird had tested ⁠positive in the...

Congo Begins Trial Of Gilead's Experimental Antiviral for Ebola Bundibugyo

Researchers in the Democratic Republic of Congo said on Tuesday they have started enrolling participants in ⁠a trial testing Gilead Sciences' experimental antiviral...

Gen Z Fitness Trend: Are Group Workouts Better?

Community fitness may improve exercise adherence and mental well-being through social support, although evidence shows that it offers few additional physical benefits.

What to Know About the US Outbreak Of Cyclosporiasis

The U.S. Centers for Disease Control and Prevention said on Tuesday it had confirmed 1,645 cases of an intestinal infection from the cyclospora parasite that causes...

Recommended News For You

Pre-operative evaluation of ovarian cancer patients using DWI-MRI is helpful.

Marstacimab Gets FDA Nod for Hemophilia A or B Without Inhibitors

Pediatric high-grade gliomas: Research reveals effective targeting with avapritinib

ctDNA-Guided Adjuvant Therapy Cuts Bladder Cancer Costs

Durvalumab Plus BCG Earns FDA Nod for Bladder Cancer

NHS Offers Targeted Radiotherapy for Early Prostate Cancer

Perioperative Anti-PD-1 in Soft-Tissue Sarcoma Boosts Disease-Free Survival

Recommended Articles For You

Genetic Testing in Cancer Prevention: BRCA Mutations and Lynch Syndrome Unlocked 

Environmental Carcinogen Exposure Screening: Advances, Clinical Implications, and Guideline-Based Approaches 

What Is Degos Disease? A Comprehensive Overview Of Symptoms, Diagnosis, and Treatment 

Interpreting Iron Studies: What Your Blood Results Really Mean  

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

For the creation of cutting-edge targeted radionuclide therapies in oncology, Bayer and Bicycle Therapeutics work together.

2.

Advanced breast cancer patients living longer thanks to improvements in treatment and care

3.

Radionuclide-Containing Combo Slows Metastatic Prostate Cancer, Improves Survival

4.

How wildfires pose challenges to cancer care

5.

New research uncovers link between cancer pathway and blood-retina barrier function

1.

Breaking Down Amyloidosis: Understanding the Disease 

2.

Angina Haemorrhagica Bullosa: What You Need to Know

3.

Unlocking the Mystery of Ovarian Cancer Staging

4.

Feline Anemia: Diagnosis and Treatment with Focus on Rasburicase Complications

5.

Blood Donation Sustainability Through Behavioral Science

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

Asian Symposium on Advancement in Hematology and Oncology

3.

Asian Symposium on Advancement in Hematology and Oncology

4.

International Cancer Conference

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

Current Scenario of Cancer- Q&A Session to Close the Gap

2.

Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part III

3.

Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part V

4.

An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- Panel Discussion- Part II

5.

Current Cancer Scenario in India- Importance of Genomic Testing & Advancement in Diagnosis and Treatment

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot